Keywords: NICE, UK, Roche, Bayer, Wyeth, Pfizer

UK’s NICE turns down renal cancer drugs from Roche, Bayer, Wyeth and Pfizer

Article | 26 August 2009

Print This

In a move that has angered cancer patient organizations, as well as four leading drugmakers, the UK’s National Institute ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in